PRAC requests more information on ambroxol

16 September 2014 - Deborah Wilkes

Archived

The European Union's Pharmacovigilance Risk Assessment Committee (PRAC) will discuss ambroxol and bromhexine at its meeting in December 2014, after requesting further information on the expectorants.

Click tags below for more information on topics:

ANSM

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: